Recursion Pharmaceuticals Inc【RXRX】株式ニュース

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

Form 8-K - Current report

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

First program to result from end-to-end use of OS to identify a novel target and new chemical matter, which...

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical...

Form 4 - Statement of changes in beneficial ownership of securities

ToucanYoucan 10時間前

$RXRX - That's why I'm planning to steadily accumulate shares - with the hope that one or more of these new treatments materializes.

👍️0

bwrbad 14時間前

high potential if delivers,

👍️0

TucsonPhil 17時間前

Good gains in past week, but looks like it is getting ready to drift lower again.

👍️0

TucsonPhil 18時間前

First patient dosed.

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-first-patient-dosed-phase-12-clinical-study

👍️0

lambchops 5日前

Glad to see the uptick! Was beaten down for a while. Too good of stock to be down for long.

LC

RXRX

👍️ 1

ToucanYoucan 5日前

$RXRX - Having a huge day here!!

👍️0

ToucanYoucan 1週前

$RXRX - Nice move up today! This will take a little time to find its footing pps-wise after the merger...imo

👍️0

TucsonPhil 3週前

Many foreign countries supplying pharmaceuticals to U.S. at exorbitant markups.

Will anything be done about that? I do not believe tariffs will help with that problem, since people either pay, whatever the cost, or suffer and die.

https://x.com/RecursionPharma/status/1841453309342740925

👍️0

TucsonPhil 2月前

So many clinical trials in work, but for this to translate to value, they will need to show high efficacy and a much shorter time-to-market, using Recursion platform. The problem may be that Recursion can identify promising candidates quickly, but the slow-moving follow-on processes will still eat up valuable time. The value proposition here is the decrease in attrition, for candidates that fail in early stage trials.

https://ir.recursion.com/news-releases/news-release-details/recursion-gives-guidance-seven-clinical-readouts-within-18

https://www.recursion.com/pipeline

https://www.stockscores.com/charts/charts/?ticker=RXRX

👍️0

lambchops 3月前

Yes. Good stock to put on watchlist IMO.
Still reasonably cheap. Check MACD.

LC

RXRX

👍️0

mick 3月前

diamond in the ruff

RXRX
Recursion Pharmaceuticals Inc
6.32
0.20 (3.27%)
Volume: 3,082,418
Day Range: 6.055 - 6.32
Last Trade Time: 4:28:47 PM EDT

👍️0

mick 3月前

RXRX
Recursion Pharmaceuticals Inc
5.95
-0.22 (-3.57%)
Volume: 4,577,882
Day Range: 5.895 - 6.30
Last Trade Time: 7:58:59 PM EDT

👍️0

lambchops 3月前

Yes, I've been adding shares of RXRX this week.

LC

RXRX

👍️0

TucsonPhil 3月前

Looks.like a little dilution, but a good buying opportunity, to add some more.

👍️0

lambchops 3月前

Judging on the reaction some investors must not have liked it either.Will be a strong company into RXRX.I like buying good companies that have a downdraft. They usually come back strong.
Please note I own shares in this company.

LC

RXRX

👍️0

TucsonPhil 3月前

I had not seen that merger announcement. Never came across in my broker news feed.

👍️0

lambchops 3月前

Did you see the possible merger news?

LC

RXRX

👍️0

TucsonPhil 3月前

Running millions of tests per week, to find promising drug candidates.

What we do not know, is how many candidates have entered clinical trials.

When news pops about RXRX origination of promising cures, this will skyrocket.

Oops, missed this one:

https://ir.recursion.com/news-releases/news-release-details/recursion-announces-phase-2-data-rec-994-first-disease

👍️0

lambchops 3月前

Looks ready to move IMO.

LC

RXRX

👍️0

TucsonPhil 3月前

Looking for a move into the 9.25-9.50 range within the next few weeks.

👍️0

lambchops 3月前

RXRX looks ready for another move upward.

Looks like RXRX is making an upward move.

👍️0

lambchops 3月前

I like RXRX even better!

LC

GOOD to own, Rxrx

👍️0

lambchops 4月前

How do you like RXRX at $6.65?

Hold this one until they discover a promising drug candidate, then play the spike and repurchase on the subsequent slump. Ofc, if they do start identifying promising drug candidates, then it could just keep going up, after proof of concept is shown.

👍️0

mick 5月前

RXRX
Recursion Pharmaceuticals Inc
7.9485
-0.4015 (-4.81%)
Volume: 2,346,108
Day Range: 7.94 - 8.48
Last Trade Time: 2:15:15 PM EDT

👍️0

Monksdream 6月前

RXRX was bought Friday by Cathie Wood for the.ARKK fund
Based on the chart it’s a buy at $5

👍️ 1

mick 6月前

Recursion Pharmaceuticals Inc (NASDAQ:RXRX)

https://www.msn.com/en-us/money/markets/hedge-funds-are-loading-up-on-this-nvidia-corp-nvda-partner-stock/ar-BB1njsU8?ocid=BingNewsSerp

https://finviz.com/quote.ashx?t=RXRX&p=d

sutter hill, investor

https://pro.manwardpress.com/p/PARTNERTO99MWLLT2YRDSCBP/NMWL4506/?s1=d0587f1afbc14e9f9b10866ff8e6d8b6&h=true

https://www.insidermonkey.com/blog/7-best-under-the-radar-ai-stocks-hedge-funds-are-buying-1307776/

👍️0

mick 6月前

RXRX
Recursion Pharmaceuticals Inc
8.79
0.21 (2.45%)
Volume: 1,471,309
Day Range: 8.60 - 8.87
Last Trade Time: 12:14:29 PM EDT

👍️0

mick 6月前

9 mos

SEVEN MOS; http://www.stockta.com/

9 mos
[-chart]www.stockscores.com/chart.asp?TickerSymbol=RXRX&TimeRange=275&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=50&avgType2=SMA&movAvg2=100&Indicator1=RSI&Indicator2=BBW&Indicator3=AccDist&Indicator4=MACD&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen[/chart]

SEVEN MOS; http://www.stockta.com/
[-chart]www.stockta.com/cgi-bin/candle.pl?cobrand=&symb=RXRX&size=analysis&support=0.00,15,0.00,66,0.00,38,0.00,14,0.00,12,0.00,15,0.00,3,0.00,2,0.00,4,0.00,6,0.00,2&trend=[/chart]

👍️0

mick 6月前

Recursion Pharmaceuticals Inc
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA).
Nvidia Invested $50 million into This AI Drug Discovery Biotech
www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discovery-biotech
www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discover…

👍️0

mick 6月前

BioHive-2, an NVIDIA DGX SuperPOD with NVIDIA DGX H100 systems, ranked #35 in the TOP500 list of the most powerful supercomputers in the world across all industries as of May 2024.

👍️0

mick 6月前

Recursion Announces Completion of NVIDIA-Powered BioHive-2, the Largest Supercomputer in Pharmaceutical Industry

👍️0

mick 6月前

https://www.otcmarkets.com/stock/RXRX/news/story?e&id=2857451

Was only a matter of time before another company jumped on the bandwagon:

"Dell Technologies and Northwestern Medicine to Advance Patient Care through AI Innovation"

https://www.prnewswire.com/news-releases/dell-technologies-and-northwestern-medicine-to-advance-patient-care-through-ai-innovation-302108735.html

Joe of Nanolyze explains RXRX

In a 100 trilliona biology yes

👍️0

jokolahd3 11月前

Looks like 5 dollars is a good buy

👍️0

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Recursion Pharmaceuticals Inc (RXRX)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

RXRX ニュース

Form 8-K - Current report

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

RXRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Recursion Pharmaceuticals Inc (RXRX) ニュース

Recursion Pharmaceuticals Inc (RXRX)

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

RXRX ニュース

Form 8-K - Current report

Recursion announces first patient dosed in Phase 1/2 clinical study of REC-1245, a potential first-in-class, RBM39 degrader for Biomarker-Enriched Solid Tumors and Lymphoma

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K/A - Current report: [Amend]

Form 8-K/A - Current report: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 8-K - Current report

Form S-8 - Securities to be offered to employees in employee benefit plans

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

RXRX Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手